Inflammation-induced DNA damage and damage-induced inflammation: A vicious cycle

Microbes and Infection

Volumn 16, Issue 10, 2014, Pages 822-832

  Pálmai Pallag, Timea ^a   Bachrati, Csanád Z ^a  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

Cell free DNA; DNA damage response; Inflammation; Oxidative DNA damage; Reactive oxygen species

Indexed keywords

DNA BINDING PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; KU ANTIGEN; MITOCHONDRIAL DNA; MRE11 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PATTERN RECOGNITION RECEPTOR; PROTEIN AIM2; PROTEIN STING; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; ANIMAL; DISEASE MODEL; GENOMIC INSTABILITY; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MUTATION; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; DNA, MITOCHONDRIAL; GENOMIC INSTABILITY; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; MUTATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 84925934160     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.10.001     Document Type: Article

References (99)

1. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
2. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
3. Babior B.M. Phagocytes and oxidative stress. Am J Med 2000, 109:33-44.
4. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 2005, 77:598-625.
5. Weiss S.J., Test S.T., Eckmann C.M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science 1986, 234:200-203.
6. Weinberg J.B., Misukonis M.A., Shami P.J., Mason S.N., Sauls D.L., Dittman W.A., et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995, 86:1184-1195.
7. Knaapen A.M., Gungor N., Schins R.P., Borm P.J., Van Schooten F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 2006, 21:225-236.
8. Cadet J., Loft S., Olinski R., Evans M.D., Bialkowski K., Richard W.J., et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res 2012, 46:367-381.
9. Gedik C.M., Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 2005, 19:82-84.
10. Malins D.C., Johnson P.M., Wheeler T.M., Barker E.A., Polissar N.L., Vinson M.A. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res 2001, 61:6025-6028.
11. Thomson L.H. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat Res 2012, 751:158-246.
12. Kazak L., Reyes A., Holt I.J. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 2012, 13:659-671.
13. Alexeyev M., Shokolenko I., Wilson G., LeDoux S. The maintenance of mitochondrial DNA integrity-critical analysis and update. Cold Spring Harb Perspect Biol 2013, 5:a012641.
14. Suzuki N., Kamataki A., Yamaki J., Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 2008, 387:55-58.
15. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665.
16. Oka T., Hikoso S., Yamaguchi O., Taneike M., Takeda T., Tamai T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485:251-255.
17. Brill A., Fuchs T.A., Savchenko A.S., Thomas G.M., Martinod K., De Meyer S.F., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012, 10:136-144.
18. Fuchs T.A., Kremer Hovinga J.A., Schatzberg D., Wagner D.D., Lammle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012, 120:1157-1164.
19. Bartoloni E., Ludovini V., Alunno A., Pistola L., Bistoni O., Crino L., et al. Increased levels of circulating DNA in patients with systemic autoimmune diseases: a possible marker of disease activity in Sjogren's syndrome. Lupus 2011, 20:928-935.
20. Pinti M., Cevenini E., Nasi M., De Biasi S., Salvioli S., Monti D., et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for "inflamm-aging". Eur J Immunol 2014, 44:1552-1562.
21. Gahan P.B., Stroun M. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 2010, 28:529-538.
22. Kostyuk S.V., Tabakov V.J., Chestkov V.V., Konkova M.S., Glebova K.V., Baydakova G.V., et al. Oxidized DNA induces an adaptive response in human fibroblasts. Mutat Res 2013, 747-748:6-18.
23. Ermakov A.V., Konkova M.S., Kostyuk S.V., Izevskaya V.L., Baranova A., Veiko N.N. Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev 2013, 2013:649747.
24. Hajizadeh S., DeGroot J., TeKoppele J.M., Tarkowski A., Collins L.V. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 2003, 5:R234-R240.
25. Cooke M.S., Herbert K.E., Butler P.C., Lunec J. Further evidence for a possible role of conformation in the immunogenicity and antigenicity of the oxidative DNA lesion, 8-oxo-2'deoxyguanosine. Free Radic Res 1998, 28:459-469.
26. Kostyuk S.V., Ermakov A.V., Alekseeva A.Y., Smirnova T.D., Glebova K.V., Efremova L.V., et al. Role of extracellular DNA oxidative modification in radiation induced bystander effects in human endotheliocytes. Mutat Res 2012, 729:52-60.
27. Blyth B.J., Sykes P.J. Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures?. Radiat Res 2011, 176:139-157.
28. Ermakov A.V., Konkova M.S., Kostyuk S.V., Smirnova T.D., Malinovskaya E.M., Efremova L.V., et al. An extracellular DNA mediated bystander effect produced from low dose irradiated endothelial cells. Mutat Res 2011, 712:1-10.
29. Suter M., Richter C. Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases. Biochemistry 1999, 38:459-464.
30. Yousefi S., Gold J.A., Andina N., Lee J.J., Kelly A.M., Kozlowski E., et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008, 14:949-953.
31. Brinkmann V., Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol 2012, 198:773-783.
32. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010, 10:403-414.
33. Li Q., Zhang J., Zhou Y., Qiao L. Obesity and gastric cancer. Front Biosci (Landmark Ed) 2012, 17:2383-2390.
34. Shokolenko I., Venediktova N., Bochkareva A., Wilson G.L., Alexeyev M.F. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res 2009, 37:2539-2548.
35. Yoshida H., Nishikawa M., Kiyota T., Toyota H., Takakura Y. Increase in CpG DNA-induced inflammatory responses by DNA oxidation in macrophages and mice. Free Radic Biol Med 2011, 51:424-431.
36. Zhang Q., Itagaki K., Hauser C.J. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 2010, 34:55-59.
37. Collins L.V., Hajizadeh S., Holme E., Jonsson I.M., Tarkowski A. Endogenously oxidized mitochondrial DNA induces invivo and invitro inflammatory responses. J Leukoc Biol 2004, 75:995-1000.
38. Saxena G., Chen J., Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem 2010, 285:3997-4005.
39. Yoshihara E., Chen Z., Matsuo Y., Masutani H., Yodoi J. Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol 2010, 474:67-82.
40. Lane T., Flam B., Lockey R., Kolliputi N. TXNIP shuttling: missing link between oxidative stress and inflammasome activation. Front Physiol 2013, 4:50.
41. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011, 12:222-230.
42. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
43. Hiramoto K., Kobayashi H., Yamate Y., Ishii M., Sato E.F. Intercellular pathway through hyaluronic acid in UVB-induced inflammation. Exp Dermatol 2012, 21:911-914.
44. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
45. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008, 9:857-865.
46. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
47. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
48. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006, 281:36560-36568.
49. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
50. Zhang J.Z., Liu Z., Liu J., Ren J.X., Sun T.S. Mitochondrial DNA induces inflammation and increases TLR9/NF-kappaB expression in lung tissue. Int J Mol Med 2014, 33:817-824.
51. Wu J., Chen Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014, 32:461-488.
52. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709-760.
53. Huang H., Evankovich J., Yan W., Nace G., Zhang L., Ross M., et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011, 54:999-1008.
54. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190-198.
55. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
56. Ding Z., Liu S., Wang X., Khaidakov M., Dai Y., Mehta J.L. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep 2013, 3:1077.
57. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010, 11:395-402.
58. Gehrke N., Mertens C., Zillinger T., Wenzel J., Bald T., Zahn S., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 2013, 39:482-495.
59. Kuechle M.K., Elkon K.B. Shining light on lupus and UV. Arthritis Res Ther 2007, 9:101.
60. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
61. Saitoh T., Fujita N., Hayashi T., Takahara K., Satoh T., Lee H., et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A 2009, 106:20842-20846.
62. Abe T., Harashima A., Xia T., Konno H., Konno K., Morales A., et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell 2013, 50:5-15.
63. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
64. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011, 12:959-965.
65. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
66. Huang Y.H., Liu X.Y., Du X.X., Jiang Z.F., Su X.D. The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat Struct Mol Biol 2012, 19:728-730.
67. Parvatiyar K., Zhang Z., Teles R.M., Ouyang S., Jiang Y., Iyer S.S., et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012, 13:1155-1161.
68. You Z., Shi L.Z., Zhu Q., Wu P., Zhang Y.W., Basilio A., et al. CtIP links DNA double-strand break sensing to resection. Mol Cell 2009, 36:954-969.
69. Kondo T., Kobayashi J., Saitoh T., Maruyama K., Ishii K.J., Barber G.N., et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A 2013, 110:2969-2974.
70. Yan H.X., Wu H.P., Zhang H.L., Ashton C., Tong C., Wu J., et al. DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats. Oncogene 2013, 32:4565-4571.
71. Volcic M., Karl S., Baumann B., Salles D., Daniel P., Fulda S., et al. NF-kappaB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes. Nucleic Acids Res 2012, 40:181-195.
72. Swindall A.F., Stanley J.A., Yang E.S. PARP-1: friend or foe of DNA damage and repair in Tumorigenesis?. Cancers (Basel) 2013, 5:943-958.
73. Ivana S.A., Diederich M. Modulation of poly(ADP-ribosylation) in apoptotic cells. Biochem Pharmacol 2004, 68:1041-1047.
74. David K.K., Andrabi S.A., Dawson T.M., Dawson V.L. Parthanatos, a messenger of death. Front Biosci (Landmark Ed) 2009, 14:1116-1128.
75. Munoz-Gamez J.A., Rodriguez-Vargas J.M., Quiles-Perez R., Aguilar-Quesada R., Martin-Oliva D., de Murcia G., et al. PARP-1 is involved in autophagy induced by DNA damage. Autophagy 2009, 5:61-74.
76. Berger N.A., Berger S.J. Metabolic consequences of DNA damage: the role of poly (ADP-ribose) polymerase as mediator of the suicide response. Basic Life Sci 1986, 38:357-363.
77. Pacher P., Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 2008, 173:2-13.
78. Ba X., Garg N.J. Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 2011, 178:946-955.
79. Zhang X., Brann T.W., Zhou M., Yang J., Oguariri R.M., Lidie K.B., et al. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol 2011, 186:4541-4545.
80. Yotsumoto S., Saegusa K., Aramaki Y. Endosomal translocation of CpG-oligodeoxynucleotides inhibits DNA-PKcs-dependent IL-10 production in macrophages. J Immunol 2008, 180:809-816.
81. Wilson H.L., Dar A., Napper S.K., Marianela L.A., Babiuk L.A., Mutwiri G.K. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides. Int Rev Immunol 2006, 25:183-213.
82. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012, 1:e00047.
83. Lange S.S., Vasquez K.M. HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic. Mol Carcinog 2009, 48:571-580.
84. Pasheva E.A., Pashev I.G., Favre A. Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain. J Biol Chem 1998, 273:24730-24736.
85. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
86. Tang D., Lotze M.T. Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol 2012, 13:808-810.
87. Tang D., Shi Y., Kang R., Li T., Xiao W., Wang H., et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007, 81:741-747.
88. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
89. Venereau E., Schiraldi M., Uguccioni M., Bianchi M.E. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013, 55:76-82.
90. Yang H., Tracey K.J. Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010, 1799:149-156.
91. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924.
92. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
93. Tadie J.M., Bae H.B., Jiang S., Park D.W., Bell C.P., Yang H., et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol 2013, 304:L342-L349.
94. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011, 29:139-162.
95. Huang W., Tang Y., Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010, 51:119-126.
96. Andersson U., Harris H.E. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta 2010, 1799:141-148.
97. Urbonaviciute V., Voll R.E. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J Intern Med 2011, 270:309-318.
98. Kang R., Zhang Q., Zeh H.J., Lotze M.T., Tang D. HMGB1 in cancer: good, bad, or both?. Clin Cancer Res 2013, 19:4046-4057.
99. Jia L., Clear A., Liu F.T., Matthews J., Uddin N., McCarthy A., et al. Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia. Blood 2014, 123:1709-1719.